Most knowledge of HR is derived from work in prokaryotic and eukaryotic model organisms. We carried out a genome-wide siRNA-based screen in human cells. Among positive regulators of HR we identified networks of DNA-damage-response and pre-mRNA-processing proteins, and among negative regulators we identified a phosphatase network. Three candidate proteins localized to DNA lesions, including RBMX, a heterogeneous nuclear ribonucleoprotein that has a role in alternative splicing. RBMX accumulated at DNA lesions through multiple domains in a poly(ADP-ribose) polymerase 1-dependent manner and promoted HR by facilitating proper BRCA2 expression. Our screen also revealed that off-target depletion of RAD51 is a common source of RNAi false positives, raising a cautionary note for siRNA screens and RNAi-based studies of HR.
The presence of double-strand breaks (DSBs) in DNA is a detrimental event, and failure to repair DSBs can cause loss of telomeric regions of chromosomes, complex translocations or cell death. In humans this can lead to severe developmental abnormalities and cancer. Organisms have evolved two main pathways for DSB repair: non-homologous end joining (NHEJ) and HR. NHEJ results in the potentially error-prone religation of DSB ends. HR is an error-free repair mechanism that operates during the S or G2 phase of the cell cycle and primarily uses the replicated sister chromatid as a template for repair 1 . HR is initiated when one strand of the DSB is resected, a process mediated by CtIP, the 5 -3 exonuclease EXOI and possibly other nucleases 2,3 . This generates a 3 single-stranded DNA (ssDNA) overhang that is protected from further degradation by RPA, a ssDNA-binding protein. RPA is displaced by the recombinase RAD51, generating a nucleoprotein filament that coordinates the search for a homologous sequence and facilitates strand invasion of the template DNA (ref. 4 ). In humans, BRCA2 and the RAD51 paralogues (RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3) promote and maintain the nucleation of RAD51, and a host of other repair proteins modulate HR in both the positive and negative direction 5 .
To probe the HR pathway in human cells, we carried out a genome-wide short interfering RNA (siRNA) screen; and through this screen, we uncovered cellular functions required for HR and identified proteins that localize to sites of DNA damage. Screen data also revealed that RAD51 is a common off-target of siRNAs, which presents a cautionary note to those studying HR with siRNAs and highlights the vulnerability of RNA interference (RNAi) screens to off-target effects in general. Among the candidates we identified as positive regulators of HR was RBMX, a heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with the spliceosome, binds RNA and influences alternative splicing 6 . We found that RBMX is required for resistance to DNA damage and accumulates at sites of DNA damage in a poly(ADP-ribose) polymerase 1 (PARP1)-dependent manner.
RESULTS

A genome-wide siRNA screen to identify regulators of HR
We carried out an siRNA screen to identify components of the mammalian HR machinery using a well-characterized GFP-based reporter 7, 8 (DR-GFP; Fig. 1a ). DR-GFP carries two mutant versions of GFP; one with two premature stop codons and an internal I-SceI endonuclease restriction site (SceGFP), the other with 3 and 5 end truncations 7 (iGFP). Neither SceGFP nor iGFP expresses a functional protein; however, a gene conversion event between the mutants-generated by recombinational repair of an I-SceI-induced DSB-can reconstitute wild-type GFP. In this manner, nuclear GFP expression is an accurate readout for HR. For our screen, we employed the osteosarcoma cell line DR-U2OS, which has a single, stably integrated copy of DR-GFP, and we drove expression of I-SceI with an adenovirus 8 (AdNGUS24i).
We screened the Dharmacon human siGENOME siRNA library in triplicate, which is arrayed as 21,121 single-target pools of four distinct siRNAs. Briefly, DR-U2OS cells were plated in 384-well plates, reverse transfected with siRNAs and infected with AdNGUS24i at a multiplicity of infection (MOI) of ∼10 ( Fig. 1b ). At this high titre, changes in cell number should have little effect on assay results ( Supplementary  Fig. S1a ). Cells were fixed, stained with Hoechst and the percentage of GFP+ cells per well was determined by fluorescence microscopy on an automated platform (Fig. 1c) . The average percentage of GFP+ cells from each experimental triplicate was normalized to that from on-plate, non-targeting control wells transfected with an siRNA against firefly luciferase (FF siRNA) to obtain a relative HR ratio for each library pool ( Fig. 1d and Supplementary Table S1 ). Indicative of a successful screen, we recovered 19 genes known to be involved in HR and the DNA-damage response (DDR), including RAD51, BRCA1 and BRCA2 (Fig. 1d,e ).
Identification and validation of candidate HR regulators
Hits from the screen were defined as siRNA pools that decreased or increased relative HR by more than 2 s.d. from the screen-wide mean (cutoff values ∼40% or 188% relative HR). From the corresponding genes, 510 candidate HR mediators and 484 candidate HR suppressors were identified ( Supplementary Table S1 ). We extended the list of 4 candidate mediators by 131 genes corresponding to siRNA pools that trended in the screen (primarily with 40-50% relative HR; Supplementary Tables S1 and S2). These additional genes had also been identified in previous DDR screens. Next we deconvolved the 641 siRNA pools against candidate mediators and the strongest 250 pools against candidate suppressors (including 1 duplicate pool) and rescreened each siRNA individually ( Supplementary Tables S2  and S3 ). As expected, siRNAs from both candidate sets enriched for the appropriate phenotype ( Fig. 2a ).
We evaluated the rescreened siRNAs with both strong and weak phenotype cutoffs ( Fig. 2b ). Strong siRNAs were those that rescored below (for mediator siRNAs) or above (for suppressor siRNAs) the 2-s.d.-based thresholds from the primary screen (40% and 188% relative HR, respectively). Weak cutoffs were based on 1.5 s.d. from the primary screen mean (< 59% or > 169% relative HR for mediators and suppressors, respectively). We considered candidate siRNA pools validated if ≥ 3 individual siRNAs (out of 4) rescored with at least a weak HR value (14% of pools for HR mediators and 20% of pools for HR suppressors; Fig. 2b ). The higher validation rate for siRNA pools targeting HR suppressors is a result of rescreening only the strongest 250 pools. The strongest scoring pools against candidate mediators also yielded a higher rate of validation ( Supplementary Fig. S1b ). We evaluated siRNA toxicity throughout and observed no correlation between cell growth and relative HR levels ( Supplementary Fig. S1c -e and Tables S1-S3; see Methods).
To further evaluate the candidate mediator list and better understand the 68% of pools that rescored with 1-2 siRNAs, we conducted a second round of rescreening using siRNAs from the Ambion Silencer Select library targeting 467 candidate mediators (3 siRNAs per gene; Supplementary Table S4 ). These siRNAs also enriched for reduced HR but at a level substantially lower than observed among Dharmacon siRNAs targeting the same 467 genes ( Fig. 2c ). We reason that the independently selected Ambion siRNAs had a reduced incidence of off-targeting and were, therefore, more likely to score true positives. Importantly, candidates that validated with 3-4 (of 4) Dharmacon siRNAs had greater likelihood of scoring with 2-3 (of 3) Ambion siRNAs (over candidates that scored with fewer Dharmacon siRNAs), even when known HR and DDR mediators were not considered ( Fig. 2d and Supplementary Fig. S1f ).
Network analysis
Next we evaluated candidate genes for enrichment of functional categories and interaction networks using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, http://www.ingenuity.com; see Methods section for a description of the gene lists submitted to IPA). Both mediators and suppressors were enriched for genes functionally categorized as DNA replication, recombination and repair, which we expected for mediators of HR, but not necessarily for suppressors, as little is known about what activities limit recombination ( Fig. 2e and Supplementary Fig. S2a ). Among candidate mediators, two gene networks with known HR genes were identified ( Fig. 2f,g) . These highlight roles for the RFC DNA clamp loader and the TIP60 histone acetylase complex in HR, and support a role for factors associated with DDB1 and the Cul4A ubiquitin ligase. Nine components of the TIP60 complex scored or trended in the primary screen: TIP60, RUVBL1, RUVBL2, DMAP1, BRD8, P400, ING3, MRGBP and MRG15. The most significantly enriched category among candidate mediators was RNA post-transcriptional modification, which also produced a strong interaction network ( Fig. 2e,h) . Although the involvement of RNA processing proteins in the DDR is poorly understood, several large-scale genetic and proteomic analyses of the DDR have shown similar enrichments [9] [10] [11] . A role in promoting HR could explain the enrichment in each screen. Among HR suppressors a small network of phosphatases emerged, which may act to limit the activity of kinases that promote HR ( Supplementary Fig. S2b ).
IPA also identified categories of candidate genes that relate to the design of the screen but not HR. The DR-GFP-based HR assay depends on infection of an adenovirus, expression of I-SceI and GFP, and normal cell-cycle progression; and it is, therefore unlikely that candidates functionally categorized under infection mechanism, gene expression and cell-cycle regulation represent biological true positives ( Fig. 2e and Supplementary Fig. S2a ). Specifically, a network of RNA polymerase II (RNAP2) and mediator subunits was identified among candidate HR mediators ( Supplementary Fig. S2c ).
Three candidate HR regulators localize to sites of DNA damage: HIRIP3, RBMX and DDX17
We made GFP fusions of 22 candidates and evaluated each for relocalization after DNA damage ( Supplementary Table S5 ). Two candidate mediators, HIRIP3 and RBMX, and one suppressor, DDX17, accumulated at regions of DNA damaged by micro-irradiation ( Fig. 3a ). RBMX is an RNA-binding protein (RBP) that associates with the spliceosome and plays a role in alternative splicing, and DDX17 is a DEAD-box RNA helicase that is phosphorylated in response to ionizing radiation 6, 9, 12 . HIRIP3 interacts with the histone chaperone HIRA and binds histones H2B and H3 (ref. 13 ). Interestingly, HIRA and two additional HIRA-associated proteins (UBN1 and CAIN) also localized to DNA damage after micro-irradiation ( Supplementary Fig. S3a ).
The HIRIP3-targeting siRNA pool gave a strong HR defect in our primary screen, but although seven siRNAs and three short hairpin RNAs (shRNAs) were individually shown to deplete HIRIP3, only five of these caused substantial HR defects; and none of three screened HIRIP3 Ambion siRNAs scored (Fig. 3b ,c and Supplementary Table S4 ). Indicative of an off-target effect, expression of siRNA-resistant HIRIP3 did not rescue the HIRIP3 siRNA 2 HR defect. The screened HIRA siRNA pool trended for decreased HR; however, indicative of a false positive, the deconvolved siRNAs caused a range of HR effects that did not correlate with messenger RNA depletion ( Supplementary  Fig. S3b ,c). Similarly, several UBN1-and CAIN -targeting siRNAs caused HR defects likely to be associated with off-target effects ( Supplementary Fig. S3c-f ). As a result of these data, we suspected that HR might be particularly sensitive to off-target effects.
Off-target RAD51 depletion contributes to screen false positives
To search for off-target effects in our screen data set we employed genome-wide enrichment of seed sequences (GESS) analysis, which identifies 3 UTRs with enriched sequence complementarity to the seed regions of siRNAs that score in genome-wide data sets (over nonscoring siRNAs) 14 . siRNA seed regions are nucleotides 2-8 of either RNA strand (sense or antisense), and seed sequence complementarity to the 3 UTR of a gene transcript is thought to elicit repression by pathways endogenously engaged by microRNA-containing RISC complexes 15, 16 . GESS analysis of our Dharmacon rescreen data revealed that siRNAs against candidate mediators with strong HR defects (40% relative HR cutoff) were threefold enriched for antisense seed sequence matches of 7-nucleotides to the 3 UTR of RAD51, compared with those that did not rescore with a strong phenotype (an increase from 8% to 25%, Fisher's exact test P = 4.65×10 −23 ; Fig. 3d ). The sense strands of these strongly Supplementary Fig. S13 .
scoring Dharmacon siRNAs, however, gave no enrichment for seed matches to the RAD51 3 UTR (Fisher's Exact Test P-value = 0.5986), and no enrichment for seed region complementarity (from either strand) to the RAD51 coding region (CDS) was observed (Fisher's exact test P = 0.8886; Supplementary Fig. S4a ). From these data, we predict a 17% false-positive rate due to off-target RAD51 depletion among our strong scoring Dharmacon siRNAs. Importantly, however, the strong scoring Ambion siRNAs against candidate mediators were not enriched for antisense (or sense) seed complementarity to the RAD51 3 UTR (Fisher's exact test P = 0.3526 antisense and 0.7485 sense), indicating that this off-target effect does not confound the data from those reagents ( Supplementary Fig. S4b ). Interestingly, GESS analysis of Dharmacon siRNAs that scored for increased HR identified enrichment of three 3 UTRs belonging to genes that have yet to be implicated in HR: ITGB1BP3, FAM153C and EDC3 ( Supplementary Fig. S4c ).
Predicted off-target RAD51 depletion was confirmed for 6 screened Dharmacon siRNAs with 7-nucleotide antisense seed region matches to the 3 UTR of RAD51 (of 7 tested), and both RAD51 mRNA and protein depletion by these siRNAs correlated with the percentage of relative HR determined for each during rescreening analysis (Fig. 3e ). The HR defects caused by four HIRIP3 siRNAs (including three from the primary screen pool) also correlated with off-target RAD51 depletion ( Fig. 3b and Supplementary Fig. S4d ). However, of these, only HIRIP3 siRNA 5 had a 7-nucleotide seed match to the RAD51 3 UTR, indicating that RAD51 off-targeting can occur without complete seed complementarity and that the incidence of RAD51 off-target effects in our screen is under-represented by the GESS-derived estimation. Consequently, we refined our list of validated candidate HR mediators to 121 that scored with at least 3 of 7 combined Ambion and Dharmacon siRNAs after eliminating Dharmacon siRNAs predicted to deplete RAD51 by a 7-nucleotide antisense seed region match to the RAD51 3 UTR ( Supplementary Table S6 ).
Candidate HR effector RBMX accumulates at regions of DNA damage in a PARP-dependent manner
Next we focused on RBMX, a second candidate that localized to DNA damage. RBMX is an hnRNP protein that regulates alternative splicing in at least two possible ways: one through RNA binding by an RNA recognition motif (RRM) and one independent of the RRM (ref. 6 ). X-linked RBMX and a Y-chromosome-encoded paralogue (RBMY ) are conserved among mammals, and in humans there are several intron-less retrogenes of RBMX present on various autosomes 17, 18 . Expression of RBMX and at least one of its retrogenes (RBMXL1) is ubiquitous throughout tissue types, whereas expression of RBMY is restricted to male germ cells, indicating a role in spermatogenesis and possibly meiosis [17] [18] [19] . RBMX has also been proposed to be a tumour suppressor 20, 21 .
GFP-RBMX localization to DNA damage was apparent in ∼20-40% of U2OS cells, and both endogenous and Flag/Ha (FHA)-tagged RBMX micro-irradiation tracks (or 'stripes') could be observed with antibodies after Triton X-100 pre-extraction ( Fig. 4a-c and Supplementary Fig.  S5a,b ). The percentage of cells with GFP-RBMX tracks increased after depletion of endogenous RBMX, indicating that background chromatin binding obscures detection ( Fig. 4a ). GFP-RBMX localization to DNA damage was transient, occurring between 0 and 10 min after micro-irradiation (longer at room temperature); and following this initial recruitment, GFP-RBMX was removed from damaged DNA, causing a localization pattern that we refer to as an 'anti-stripe' (Fig. 4b,c and Supplementary Fig. S5c ). HA-tagged and endogenous RBMX formed anti-stripes as well ( Supplementary Fig. S5a,b ). We failed to observe RBMX accumulation at ionizing-radiation-induced foci, although this may be a consequence of low signal-to-noise ratio or the transient nature of RBMX recruitment. We previously showed that RNAP2 forms anti-stripes after micro-irradiation in a manner correlated with transcriptional repression at sites of active DNA repair 22 . Consistent with this interpretation, we also observed anti-stripe localization of other hnRNP proteins after micro-irradiation ( Supplementary Fig. S5d ).
RBMX recruitment to DNA damage was independent of ATM signalling and H2AX but dependent on PARP1 ( Fig. 4c and Supplementary Fig. S6a -c). PARP1 mediates recruitment of repair proteins to DNA damage through the transient polymerization of branched poly(ADP-ribose) (PAR) structures; and it is likely that RBMX localization is similarly facilitated 1, 22, 23 . GFP-RBMX track formation occurred coincidentally with PAR formation at breaks, and inhibition of PARP1 (by either the chemical inhibitor KU-0058948 or by siRNA mediated depletion) prevented GFP-RBMX track formation and caused early formation of anti-stripes ( Fig. 4c and Supplementary  Fig. S6a,b,d ). Furthermore, siRNAs against PARG, the PAR disassembly enzyme, increased the percentage of cells with GFP-RBMX tracks after micro-irradiation and prolonged localization at damage ( Fig. 4c ).
RBMX promotes DNA repair by HR
The RBMX siRNA pool in our primary screen decreased HR to 7% of controls, comparable to the effect of depleting BRCA2 and RAD51 (5% and 11%, respectively). All four siRNAs from this pool (RBMX siRNA 1 to 4), as well as two Ambion siRNAs (RBMX siRNA 5 and 6) and three independently selected shRNAs (RBMX shRNA 7, 9 and 10), caused defective HR in a manner correlating with RBMX depletion ( Table S4 ). We ruled out obvious off-target effects for these RNAi reagents, and found that stable expression of siRNA-resistant FHA-tagged RBMX rescued the HR defect associated with RBMX siRNA 3 ( Fig. 5d ,e and Supplementary Fig. S7b-g ). There were no confounding effects on cell-cycle distributions in the rescue assay ( Supplementary Fig. S8a,b) .
RBMX -targeting siRNAs also sensitized cells to DNA-damaging agents that engage the HR machinery for repair, including DSBinducing ionizing radiation, replication-stress-inducing camptothecin and several crosslinking agents (mitomycin C, chlorambucil, oxaliplatin and carboplatin; Fig. 5f ,g). The sensitivity to mitomycin C caused by RBMX siRNA 3 was significantly attenuated in cells transduced with an siRNA-resistant FHA-RBMX complementary DNA ( Fig. 5g ). Interestingly, RBMX -targeting siRNAs also caused sensitivity to ultraviolet light and tert-butyl hydroperoxide (tBHP), both of which cause DNA lesions not primarily repaired by HR ( Fig. 5f ,h). As PARP is important for the repair of single-strand DNA breaks induced by tBHP, sensitization of cells to tBHP by RBMX depletion is consistent with a role for RBMX in PARP-mediated repair.
RBMX influences HR by facilitating proper expression of BRCA2
Next we evaluated the effect of RBMX depletion on known HR events, specifically RAD51 nucleation onto resected ssDNA and the Supplementary Fig. S8c,d ). Although the RNAi reagents used in these experiments (RBMX siRNAs 1 and 3) and others caused some reduction to RAD51 protein levels (but not RAD51 mRNA), the reduction caused by RBMX siRNA 3 (unlike HR) was not rescued by siRNA-resistant FHA-RBMX, indicating that there is a negligible, RBMX-independent effect of the siRNAs on RAD51 levels (Supplementary Figs S7b,e, S8a). RBMX was not required for RPA2 or CHK1 phosphorylation after ionizing-radiation or camptothecin treatment, indicating that, in the absence of RBMX, resection at breaks proceeds properly ( Supplementary Fig. S9a-c) .
To determine the region(s) of RBMX responsible for promoting HR and facilitating localization to DNA damage, we tested a series of GFP-and FHA-tagged RBMX mutants ( Supplementary Fig. S10a-d ).
Deletion and point mutation of the conserved nucleotide-interacting residues in the RRM rendered the siRNA-resistant FHA-RBMX unable to rescue HR comparable to wild-type siRNA-resistant FHA-RBMX at the indicated levels of expression; however, when evaluated at higher expression levels the deletion mutant showed better rescue of HR, indicating that this and other mutants may not be completely defective. The RRM was dispensable for DNA damage localization. Interestingly, two non-overlapping fragments of the amino and carboxy termini localized to DNA-damage tracks, indicating that two distinct regions mediate RBMX recruitment to damage. Next, we investigated whether RBMX localization to DNA damage is required for HR; and surprisingly, we found that HR efficiency was not decreased under PARP inhibition or depletion conditions that prevented RBMX accumulation at DNA damage ( Supplementary Fig. S11a,b ). PARP1 depletion also did not substantially alter HR in an RBMX-independent manner ( Supplementary Fig. S11c ). 
Percentage of
Carboplatin (10 µM) resistance to DNA-damaging agents 34 . Briefly, U2OS cells expressing GFP and transfected with the indicated siRNAs were mixed in a 1:1 ratio with dsRed U2OS cells transfected with FF siRNA. Cell mixtures were treated with the indicated DNA-damaging agents, and after 8 days, the relative survival of GFP to dsRed cells was determined by FACS analysis. GFP/dsRed ratios were normalized to those from undamaged pools to control for the relative growth effects of the siRNAs. Error bars represent ±s.d. across three replicates. (g) DR-U2OS cells transduced with the indicated cDNAs and then transfected with the indicated siRNAs were treated with 45 nM mitomycin C, and after 7 days relative resistance was determined by the CellTiter-Glo luminescent cell viability assay. Error bars represent ±s.d. across three replicates. (h) U2OS cells transfected with the indicated siRNAs were treated with tBHP (for 1 h) or ultraviolet light, and after 5 days relative resistance was determined by the CellTiter-Glo luminescent cell viability assay. Error bars represent ±s.d. across three replicates. Full scans of blots in c and e are shown in Supplementary Fig. S13 .
As rapid recruitment of RBMX to DNA lesions was not important for HR, we reasoned that RBMX might promote HR by influencing protein expression through prerequisite splicing events. Whereas RBMX depletion had no effect on some repair proteins we tested, including PALB2, BRCA1 and RPA2 (and no effect on BRCA1 foci formation), we found that BRCA2 (and to some extent ATR) levels were decreased by RBMX siRNAs in a manner that could be rescued by stable expression of siRNA-resistant FHA-RBMX (Fig. 6d,e and Supplementary Fig. S12a-e ). Prompted by these results, we evaluated siRNAs against seven additional pre-mRNA-processing genes identified as candidate HR mediators by our screen and found that some of these also had an effect on BRCA2 expression ( Supplementary Fig. S12f-j) .
DISCUSSION
Here, we describe an unbiased screen to identify regulators of the mammalian HR machinery that yielded two candidate gene sets (510 positive and 484 negative regulators). We present these lists as a well-curated resource. Of 510 candidate mediators, we have validated 121 with ≥ 3 individual siRNAs. This validated list contains known HR proteins, including the recently characterized 9-1-1 complex-interacting protein RHINO, as well as uncharacterized HR proteins 24 . Among these is C4ORF21, which was recently shown to influence crosslink repair in a genome-wide screen for sensitivity to mitomycin C and contains a predicted DNA-binding domain and helicase-like region 25 . Both candidate sets will aid future characterization of HR regulation; and, as it is known that NHEJ proteins suppress HR, the suppressor gene set may also yield positive regulators of NHEJ (ref. 26 ). This suppressor set may also contribute to genetic engineering studies of gene targeting in mammalian cells.
A profound RAD51 off-target effect was identified in our screen using GESS analysis, a recently developed method for identifying 3 UTR sequences that have enriched complementarity to seed regions of siRNAs that score in genome-wide data sets (over non-scoring siRNAs). This effect was facilitated primarily by antisense seed regions, indicating that the Dharmacon siGENOME reagents used in our screen successfully limited off-target effects to some extent by controlling which siRNA strand was loaded into RISC using the thermal asymmetry rules. Nevertheless, we confirmed off-target depletion of RAD51 mRNA and protein by 6 of 7 screened siRNAs with antisense seed complementarity to the RAD51 3 UTR (Fig. 3e ). However, we also identified screened and independently selected siRNAs that reduced RAD51 in an off-target manner without a full 7-nucleotide antisense seed match to the 3 UTR, including HIRIP3 siRNA 1, HIRIP3 siRNA 2, HIRIP3 siRNA 4, UBN1 siRNA 2, UBN1 siRNA 3 and CAIN siRNA 2 ( Fig. 3b and Supplementary Figs S3e,f and S4d) . Therefore, additional mechanisms of RAD51 off-targeting by siRNA may be common, and RAD51 hypersensitivity to RNAi may confound study results even when RNAi reagents are chosen without selective pressure. Importantly, however, the use of independent siRNA reagents from Ambion allowed us to eliminate most off-target effects from the screen and will be a useful quality-control strategy for future screens.
It is tempting to speculate that some as yet unidentified structural element within the RAD51 mRNA hypersensitizes this particular transcript to siRNA-mediated depletion, such as a microRNA enhancer. The study outlining the development of GESS presents a focused siRNA screen for regulators of the spindle assembly checkpoint and identifies MAD2 as an enriched off-target 14 . The cell-cycle-regulated expression of RAD51 and MAD2 may aid their hypersensitivity to RNAi because they would presumably take less time to deplete than a stable protein.
Undoubtedly, however, a key aspect of their hypersensitivity must be that both are critical effectors in the pathways of inquiry. In HR, the highly cooperative RAD51 filament assembly on ssDNA should be exquisitely sensitive to protein levels. siRNA-based experiments that could be confounded by MAD2 and RAD51 off-targeting should be interpreted with caution, and previous work that may have been influenced by these effects should be revisited, as was done for a spindle-checkpoint defect we previously reported to be caused by an siRNA targeting the TAO1 kinase, which did not reproduce with additional RNAi reagents and was later determined to be a result of MAD2 off-targeting [27] [28] [29] .
During the course of this work another screen for HR genes was carried out using the endoribonuclease-prepared siRNA platform, an arrayed library of single-target siRNA pools generated from long double-stranded RNA molecules 30 . A comparison of HR mediators identified by that screen and our validated mediator list yields seven common genes, a small but significant overlap (Fisher's exact test P = 5.39 × 10 −8 ). GESS analysis could not be applied to their data set because it was not validated with individual siRNAs; however, we note that on average approximately 1 of 16 siRNAs will have a 7-nucleotide seed match to a 1-kilobase-long region of DNA (approximately the size of the RAD51 3 UTR), so multiple seed matches to RAD51 are expected to be present in each endoribonuclease-prepared siRNA pool.
We have identified the RBP and splicing regulator RBMX as an effector of HR. The enrichment of additional RNA processing factors among our candidate HR mediators and the identification of similar networks in other large-scale studies of the DDR have made it difficult to ignore the notion that RNA processing and DNA repair functionally intersect [9] [10] [11] . Roles for a few specific RBPs in the DDR have already been elucidated, and our study extends this body of work by establishing that RBMX localizes to sites of DNA damage [31] [32] [33] . The biochemical consequences of transiently accumulating RBMX to sites of damage remains to be determined. It is possible that the ability of RBMX to localize at these sites through two independent interaction domains could help to bundle PAR structures and hold breaks together to facilitate DNA repair. It is also possible that RBMX localizes a specific noncoding RNA to sites of breaks to facilitate repair. Importantly, however, the role of RBMX in HR is probably through indirect regulation of BRCA2, possibly due to a prerequisite splicing event. BRCA2 and ATR are large genes that contain a considerable number of exons (26 and 47 respectively), which may render them particularly susceptible to misregulated splicing. We reason that depletion of splicing factors in general may cause defective DNA repair through mis-splicing or alternative splicing of key effectors and reason that the pre-mRNA-processing genes on our candidate list probably represent indirect, but biologically significant, components of DNA repair.
In this work, we provide a set of genes involved in HR as a foundation on which future studies can build. In addition to the biological insights herein, we have shown that siRNA screens can be plagued by off-target effects in a significant manner. This provides a note of caution in interpreting siRNA screen results and argues strongly that each screen be subject to a search for significant off-targets. Supplementary Table   S7 . Secondary antibodies for immunofluorescence microscopy were Alexa Fluor 488 and 594 conjugated (Invitrogen). Secondary antibodies for western blots were from Jackson Laboratory. The PARP inhibitor (KU-0058948) was used at 1 µM (from KuDOS Pharmaceuticals, provided by S. Boulton). The ATM inhibitor (KU-55933) was used at 10 µM (Sigma).
METHODS
Methods
Antibodies and inhibitors. Primary antibodies are listed in
Plasmids, shRNAs, siRNAs and real-time quantitative PCR. RBMX, HIRIP3,
DDX17, RBMY, HNRNPK, HNRNPC and histone H3 cDNAs were from hORFeome V5.1. Full-length RBMX, HIRIP3 and histone H3 were verified by sequencing. The 5 ends of DDX17, RBMY, HNRNPK and HNRNPC were verified by sequencing. Mutants with point mutations and internal deletions were generated using the QuikChange II site-directed mutagenesis kit (Agilent Technologies). Truncation fragments were generated by PCR and cloned into the pENTR/D-TOPO vector using pENTR directional TOPO cloning kit (Invitrogen). Mutants and truncations were verified by sequencing. The RBMX -siRNA-3-resistant RBMX cDNA was made by mutating the RBMX siRNA 3 complementary site 5 -CAAGTTCTCGTGATACTAG-3 to 5 -CTTCCAGCAGAGACACCCG-3 . cDNAs were cloned into pMSCV-N-HA-Flag-GAW-IRES-PURO or pMSCV-N-EGFP-GAW-PGK-PURO using the Gateway recombination system. shRNAs were used in the pSMP-MSCV-PURO vector (Open Biosystems). siRNAs were transfected into cells at 10-50 µM using either Oligofectamine or Lipofectamine RNAiMAX transfection reagents (Invitrogen) according to the manufacturer's instructions and cells were processed for indicated experiments 2-3 days later. shRNA and siRNA sequences are listed in Supplementary Tables S2-S4 , S8 and S9. Multiple negative control siRNAs (FF siRNAs) and multiple positive control siRNAs (or pools) targeting the same gene were used throughout-from Dharmacon, Invitrogen and Ambion-and the particular controls used in each experiment were (usually) matched to the supplier of the experimental reagents. RNA was isolated from cells using the RNAeasy Plus kit (Qiagen) and reverse transcribed into cDNA using SuperScript III reverse transcriptase (Invitrogen #18080-044) according to the manufacturer's instructions. Real-time quantitative PCR (rt-qPCR) was carried out using Platinum Cybergreen Super Mix with Rox dye (Invitrogen #11733-046) on an Applied Biosystems 7500 Fast PCR machine. rt-qPCR primers can be found in Supplementary Table S10 .
HR assay and HTP screening protocol. The primary screen was carried out using 21,121 siRNA pools from the Dharmacon human siGENOME siRNA library (G-005000-05) at 50 nM. Dharmacon and Ambion rescreens were conducted at 20 nM. For the HTP screening, DR-U2OS cells were plated on 384-well plates at 700 cells per well and reverse transfected with siRNAs using Oligofectamine transfection reagent. Positive and negative (FF siRNA) controls were added to each plate. After 72 h, cells were infected with the I-SceI-carrying adenovirus AdNGUS24i (provided by F. Graham) at an estimated MOI of 10; 48 h after infection, cells were fixed in 3.7% formaldehyde and stained with Hoechst 33342 at a dilution of 1:5,000 (Invitrogen). Changes were made to this protocol for screening Ambion siRNAs: 500 DR-U2OS cells per well were plated (to adjust for reduced toxicity of Ambion siRNAs observed in controls); the Lipofectamine RNAiMAX transfection reagent was used; and AdNGUS24i was used at an MOI of ∼15 (to adjust for differences between viral preparations). Automated imaging of screen plates (2-4 images per well in 2 channels) was conducted on an Image Express Micro microscope (Molecular Devices) at ×4 magnification (488 nm and 350 nm wavelengths were used to detect GFP expression and Hoechst-33342-stained DNA, respectively). Automated counting of GFP+ and Hoechst-stained nuclei was carried out for each image with Metamorph Cell Scoring software (Molecular Devices), and a ratio of GFP+ cells to Hoechst-stained (total) nuclei was calculated for each well using all corresponding images. Primary screen pools, Ambion siRNAs and deconvolved Dharmacon siRNAs against candidate suppressors were evaluated in triplicate; Dharmacon siRNAs against candidate mediators were evaluated in duplicate. Any contaminated wells were eliminated from analysis. To normalize day-to-day variability, the average percentage of GFP+ cells from each triplicate (or duplicate) was normalized to the average percentage of GFP+ cells from on-plate negative control wells (FF siRNA). These normalized values are the relative HR ratios, and s.d. was calculated and propagated for each. Select images from the primary screen and Dharmacon rescreen of candidate mediators yielding high s.d. were visually inspected, and data from images that were found to contain an irregularity (for example, were out of focus) were deleted. A cell number per well value was calculated for each well as the sum of Hoechst-33342-stained nuclei from all corresponding images, and a relative cell growth ratio for each siRNA pool was calculated by normalizing the average cell number per well of corresponding experimental wells to that of on-plate negative control wells (FF siRNA). The number of images taken of experimental and corresponding control wells was the same.
The procedure for low-throughput HR assays was similar to the HTP protocol (above), except: DR-U2OS cells were either forward or reverse transfected in 6-well plates; AdNGUS24i was used at an exact MOI of 10; and GFP+ ratios were determined ∼36-48 h post infection by FACS analysis on a BD LSRII flow cytometer (BD Biosciences).
Candidate selection. Primary screen data were collected and processed as described above in the HR assay and HTP screening protocol section. All relative HR ratios from the primary screen were compiled, and from this, 519 pools that decreased relative HR by more than 2 s.d. from the screen-wide mean and 486 pools that increased relative HR by more than 2 s.d. (including 2 duplicate pools against SMAD1 and TIAM2) were identified (screen mean = 1.14, s.d. = 0.37; Supplementary Table S1 ). siRNA pools that were unavailable for validation, corresponded to discontinued gene entries in the NCBI database or (as stated above) were determined by visual analysis to be based on poor-quality imaging were eliminated. The 510 and a subset of the strongest 486 siRNA pools remaining (against 510 and 484 HR mediator and suppressor candidates, respectively) were deconvolved into individual duplexes and rescreened ( Supplementary Tables S2 and  S3 ). For this, 131 pools (against 131 genes) were added to the 510 candidate pools against HR mediators (for 641 candidates, 2564 siRNAs in total). Selection of the 131 additional candidates is described in the results section. Only the 250 pools (including 1 duplicate pool against SMAD1) that most strongly increased HR were rescreened. siRNAs from the Ambion Silencer Select library targeting 467 (of 641) candidate HR mediators were also screened (3 siRNAs per gene, 1401 siRNAs in total). Selection of these 467 candidates was based on data from our primary screen and Dharmacon rescreen analysis, as well as data from related DNA-damage screens, GESS analysis and published information about each gene.
IPA was conducted on the candidate HR mediator and suppressor sets generated by applying a 2 s.d. cutoff to the primary screen data and before the expansion/editing of the candidate lists outlined above (519 mediators and 484 suppressors; Supplementary Table S1 ). These gene sets were uploaded into IPA software and scanned for functional enrichment and interaction networks on the basis of information in the Ingenuity Knowledge Base. Select functional enrichment categories are shown in Fig. 2e and Supplementary Fig. S2a . Enrichment P values were determined by IPA using the Fisher's exact test. Select protein networks are shown in Fig. 2f-h and Supplementary Fig. S2b ,c. Network nodes are coloured according to the number of siRNAs that scored using a weak cutoff value based on 1.5 s.d. from the primary screen mean.
Cell growth analysis of primary screen and both Dharmacon and Ambion rescreens.
Throughout the primary screen and rescreening analyses we evaluated the relative level of cell growth in siRNA-transfected cells (Supplementary Tables S1-S4; see the HR assay and HTP screening protocol section above). Depletion of many HR proteins is toxic to cells, and we observed that siRNAs against candidate mediators from our screen were enriched for those that adversely affected cell growth ( Supplementary Fig. S1c ). Of 519 siRNA pools that scored for decreased HR in the primary screen, 14% resulted in final cell numbers that were less than 25% of control cells, compared with 2% of pools from the rest of the screen, which is a 7-fold enrichment for decreased cell growth (Fisher's exact test P = 1.30 × 10 −41 ). Toxicity was, likewise, prevalent in both rescreening analyses of candidate HR mediators ( Supplementary Fig. S1c-e ). However, we observed no correlation between relative cell growth and relative HR (even among siRNAs targeting known HR proteins).
GESS off-target analysis. GESS off-target analysis was conducted as previously described 14 . A total of 2,564 Dharmacon siRNAs (from 641 pools) and 1,401 Ambion siRNAs against candidate HR mediators, as well as 1,000 Dharmacon siRNAs (from 250 pools, including 1 duplicate pool) against candidate HR suppressors, were each submitted to GESS analysis. Significance P values were determined as follows. The Yates chi-squared statistic and associated one-tailed P value were calculated for each database sequence evaluated (3 UTR or CDS) if all siRNA categories (active siRNAs with or without matching, inactive siRNAs with or without matching) had more than 20 seed match events. Otherwise, a two-sided P value was calculated from the Fisher's exact test. The transcript sequences were ranked from lowest to highest P value and the statistical significance was determined by comparing the P value with a P value threshold (0.05) corrected for multiple hypothesis testing using the Benjamini and Hochberg (Simes') method.
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Ultraviolet-laser-and ionizing-radiation-induced DNA damage and immunofluorescence microscopy. Ultraviolet-laser-induced damage was generated as previously described 35 . Cells were sensitized to ultraviolet-A laser (λ = 355 nM) by 24 h pre-treatment with 10 µM BrdU and micro-irradiated using a PALM MicroBeam with fluorescence illumination (Zeiss) at 40-45% laser power. Ionizingradiation-induced damage was generated by timed exposure to a caesium-137 source. After damage, cells were allowed to recover for the indicated times at either room temperature or 37 • C and then fixed in 3.7% formaldehyde for 10 min at room temperature. Fixed cells were washed twice with PBS, permeabilized in 0.5% NP-40, washed twice with PBS and blocked with PBG (0.2% (w/v) cold fish gelatin and 0.5% (w/v) BSA in PBS) for 30 min before immunostaining with the indicated antibodies diluted in PBG. DNA was stained with DAPI by addition of Vectashield mounting medium (Vector Laboratories). GFP was observed directly. Images were collected on an Axioplan2 Zeiss microscope with a AxioCam MRM Zeiss digital camera and Axiovision 4.5-4.8 software. Images intended for comparison were prepared from the same experiment with the same exposure times, and were processed for brightness and contrast in an identical manner. Those not intended for comparison and not prepared in this way are indicated.
Cell-cycle analysis. Cells were prepared for cell-cycle analysis using the BD Pharmingen APC BrdU flow kit according to the manufacturer's instructions. Cell-cycle profiles were obtained by FACS analysis on a BD LSRII flow cytometer (BD Biosciences).
Sensitivity assays.
Multicolour competition assays were carried out as previously described 34 . For the CellTiter-Glo luminescent cell viability assay (Promega), cells were transfected with the indicated siRNAs and treated as indicated after 2-3 days. After recovery from treatment, the medium was changed and CellTiter-Glo reagent was added (1:17.5 dilution). The resulting luminescent signal (proportional to the amount of ATP) was read on a VICTOR X5 multilabel plate reader (PerkinElmer). The signal from each treatment condition was normalized to an untreated control to adjust for the relative growth effects of the siRNAs. Data from both assays are presented normalized to that from control transfected cells (FF siRNA). (e) Whole-cell extracts from U2OS cells transfected with the indicated siRNAs were immunoblotted with antibodies against UBN1, Rad51 or Actin / vinculin (loading controls). siCtrl does not target UBN1 and was used as a negative control. Two western blots of the same extracts are presented and panels are grouped accordingly. (f) Whole-cell extracts from U2OS cells transfected with the indicated siRNAs were immunoblotted with antibodies against Rad51 or vinculin (VCL, loading control). Analysis shows siCAIN-2 off-target depletion of Rad51. Full scans of blots in e and f are shown in Supplementary Information, Fig. S13 . Figure S4 GESS analysis of Dharmacon and Ambion siRNA rescreens, and Rad51 off-target analysis of siRNAs against HIRIP3. (a) Scatter plots representing the percentage of siRNAs in 2 groups that have at least one 7-nucleotide seed sequence match (either guide or passenger strand) to 39,338 human CDSs (coding sequences). Left plot: compares Dharmacon siRNAs that rescored for decreased HR with a strong phenotype (y-axis) to those that did not (x-axis). Right plot: compares the same 2 groups of siRNAs after scrambling the seed sequences and serves as a control. One CDS significantly enriched for seed matches and is indicated in red. (b) Scatter plots representing the percentage of siRNAs in 2 groups that have at least one 7-nucleotide antisense seed sequence match to 27,534 human 3'UTRs. Left plot: compares Ambion siRNAs that rescored for decreased HR with a strong phenotype (y-axis) to those did not (x-axis). Right plot: compares the same 2 groups of siRNAs after scrambling the seed sequences and serves as a control. No 3'UTR significantly enriched. (c) Scatter plots representing the percentage of siRNAs in 2 groups that have at least one 7-nucleotide seed sequence match (either strand) to 27,534 human 3'UTRs. Left plot: compares the set of Dharmacon siRNAs that rescored for increased HR with a strong phenotype (y-axis) to those that did not (x-axis). Right plot: compares the same 2 groups of siRNAs after scrambling the seed sequences and serves as a control. Three 3'UTRs (labeled) significantly enriched for seed matches and are indicated in red. Figure S6 RBMX recruitment to DNA damage requires PARP1 activity, but not H2AX or ATM signaling. (a) U2OS cells expressing GFP-RBMX were treated with an inhibitor against ATM (ATMi) or PARP (PARPi), or DMSO (untreated) and after 1 hour were microirradiated (one at a time for 5 minutes). At the indicated times cells were processed for immunofluorescence with an antibody against γH2AX. Damaged cells (as indicated by γH2AX staining) were counted for GFP-RBMX stripes (left) or anti-stripes (right) (approx. 80-160 cells / condition, n=1). (b) RBMX stripe formation was inhibited by PARP1-targeting (but not PARP2-targeting) siRNAs and stabilized by siRNAs against PARG. U2OS cells expressing GFP-RBMX and transfected with the indicated siRNA pools were microirradiated (one at a time for 5 minutes) and processed immediately for imaging with an antibody against γH2AX. GFP was observed directly. Nuclei were stained with DAPI. The percentages of cells with GFP-RBMX accumulation at gH2AX stained laser tracks are indicated (approx. 90-300 cells / condition). Data represent the mean of two replicates except for siFF, which was performed in triplicate. Scale bars indicate 20 mm. (c) H2AX-/-mouse embryonic fibroblasts (MEFs) and an isogenic cell line reconstituted with H2AX (H2AX+/+) expressing GFP-RBMX were microirradiated (one at a time for 5 minutes) and immediately processed for imaging with an antibody against PARP. GFP was observed directly. Nuclei were stained with DAPI. The percentages of cells with GFP-RBMX accumulation at gH2AX stained laser tracks are indicated (approx. 80-140 cells / condition, n=1). Scale bars indicate 10 mm. (d) GFP-RBMX stripe formation was coincident with accumulation of PARP and PAR at laser tracks but prior to RPA accumulation. U2OS cells were microirradiated (one at a time for 5 minutes) and processed for immunofluorescence with antibodies against gH2AX and PARP, PAR or RPA at the indicated times. U2OS cells expressing GFP-RBMX were similarly microirradiated and processed for immunofluorescence with an antibody against gH2AX. GFP was observed directly. Damaged cells were evaluated for the indicated stripes at gH2AX stained laser tracks (approx. 90-210 cells / condition, n=1). Fig. 6a and Supplementary Information, Fig. S8c . Full scans of blots in a-c are shown in Supplementary Information, Fig. S13 . Supplementary Figure 8 Figure S10 Structure-function analysis of RBMX. RBMX is composed of four identifiable regions: an N-terminal RNA recognition motif (RRM), a centrally located RBM1CTR region identified as common among RBMY-like hnRNPs, a C-terminus rich in serine, arginine, gylcine, and tyrosine residues, and a putative second RNA binding domain at the C-terminal end (C-RBD) 1 . The canonical RRM of RBMX preferentially binds CC(A/C)-rich single-stranded RNA; and although RBMX can influence alternative splicing in an RRMindependent manner, evidence suggests that some splicing is directly facilitated through the RRM 2 . (a) A graphical representation of RBMX mutants and their corresponding phenotypes. Flag/HA-tagged mutants were evaluated for capacity to attenuate the defect in HR caused by depletion of endogenous RBMX (data in b-d). NT indicates not tested. GFP-tagged mutants were evaluated for localization to DNA damage after microirradiation (data is from 12 separate experiments preformed with subgroups of the mutants). The ptRNP mutant carries point mutations of four aromatic residues important for the RNA binding of conserved RNA recognition motifs (RRMs): F11A, R49A, F51A and F53A. The ΔRNP mutant has deletions of two ribonucleoprotein (RNP) domains (amino acids 10-15 and 49-56) containing these conserved residues. Nuclear localization of all GFP-RBMX mutants except for the 1-93 amino acid truncation was observed. An NLS was added to the 1-93 and 218-341 amino acid fragments to aid nuclear localization; 218-341 GFP tracks were rarely observed without the NLS. +/-indicates that GFP damage tracks were rarely observed without depletion of endogenous RBMX. figure) . (e) Whole-cell extracts from DR-U2OS cells transduced with the indicated cDNAs (FHAtagged) and then transfected with the indicated siRNAs were immunoblotted with antibodies against ATR and vinculin (VCL, loading control). The same cells were evaluated in Figure 6c , e. (f) HR assay results from DR-U2OS cells transfected with the indicated siRNAs that (except for those against hnRNPUL1) target pre-mRNA processing genes that scored as candidate HR mediators. (g-j) Whole-cell extracts from cells in f were immunoblotted with antibodies against BRCA2 and vinculin (VCL, loading control). Full scans of blots in a-b, d-e, g-j are shown in Supplementary Information, Fig. S13 . 
